Tissue Diagnostics Market, by Product Type (Consumables [Antibodies, Kits, Reagents, and Probes] and Instruments [Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments]), Technology Type (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management, and Special Staining), Disease Type (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Diseases), End-User Type (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others), and by Region (North America, Europe, Asia-Pacific, and the Rest of the World).
Tissue Diagnostics Market, by Product Type (Consumables [Antibodies, Kits, Reagents, and Probes] and Instruments [Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments]), Technology Type (Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Ma...
"The global tissue diagnostics market is expected to grow from USD 5.56 billion in 2022 to USD 8.23 billion by 2028 at a CAGR of 6.75% during the forecast period of 2022-2028."
Tissue diagnostics is the process of documenting a specific tissue obtained. It can also be defined as the diagnosis of a specific tissue, including its measurement and description, as well as the observation of any abnormalities that may be present. This procedure aids in determining the patient's health and disease status. Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and in-situ hybridization are the three major types of tissue diagnostics, with immunohistochemistry (IHC) being the most popular.
The high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness are the major factors driving the growth of the market. In addition, technological advancements in the field of tissue diagnostics and the aging population are further expected to bolster the growth of the market during the forecast period.
"Theconsumables segment accounted for the largest market share."
Based on the product type, the market is segmented into consumables and instruments. The consumables segment is expected to register higher growthduring the forecast period. The growth of the segment is attributed to the cost-effectiveness and ease of use of consumables. Furthermore, the growing number of reagent rental agreements is also one of the major factors driving the growth of the consumables market.
Technology Insights
"Theimmunohistochemistry segment accounted for the largest market share."
Based on the technology type, the market is segmented as immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. The immunohistochemistry segment is expected to leadthe market over the forecast period. The increasing number of chronic diseases can be attributed to the segment's growth, where this technology is mostly used in tissue diagnostics.
Disease Insights
"Breast cancer segment accounted for the largest market share."
Based on the disease type, the market is segmented as breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other diseases. Breast cancer is expected to be the dominant disease type during the forecast period due to its increasing number of cases. In addition, advancements in the field of tissue diagnostics and an increase in investment for the development of products for breast cancer diagnosis are expected to contribute to the growth of the segment during the forecast period.
Regional Trends
"North America accounted for the largest market share."
In terms of regions, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. Among these regions, North America is expected to be dominant throughout the forecast period. The market growth in this region is majorly due to the aging population, the increasing number of cancer cases, and increasing healthcare expenditures. In addition, infrastructure development for hospitals and clinical laboratories is expected to drive the growth of the regional market during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities over the forecast period.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market.
What deliverables will you get in this report?
Key questions this report answers
Relevant contents in the report
How big is the sales opportunity?
In-depth analysis of the Tissue Diagnostics Market
How lucrative is the future?
Market forecast and trend data and emerging trends
Which regions offer the best sales opportunities?
Global, regional and country level historical data and forecasts
Which are the most attractive market segments?
Market segment analysis and forecast
Which are the top players and their market positioning?
Porter’s five forces analysis, PEST analysis, Life cycle analysis
What are the factors affecting the market?
Drivers & challenges
Will I get the information on my specific requirement?
10% free customization
The tissue diagnostics market is segmented into the following categories:
By Product Type:
Consumables
Type Analysis: Antibodies, Kits, Reagents, and Probes
Instruments
Type Analysis: Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments
By Technology Type:
Immunohistochemistry
In Situ Hybridization
Digital Pathology and Workflow Management
Special Staining
By Disease Type:
Breast Cancer
Gastric Cancer
Lymphoma
Prostate Cancer
Non-Small Cell Lung Cancer
Other Diseases
By End-User Type:
Hospitals
Research Laboratories
Pharmaceutical Companies
Contract Research Organizations
Others
By Region:
North America (Country Analysis: the USA, Canada, and Mexico)
Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)
Research Methodology
This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.
Customization Options
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Detailed profiling of additional market players (up to 3 players)
SWOT analysis of key players (up to 3 players)
Competitive Benchmarking
Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].
Share Your CommentEnter your contact details so our analysts can reach out to you
The report is delivered digitally through our online portal. Buyers receive login credentials from our team to access the report and may update their credentials at any time after the initial login.
Delivery timelines depend on the status of the report:
Published reports are typically delivered within 24 hours.
If the dataset is ready but the report is still being prepared, the dataset is usually delivered within 24 hours, while the completed report is delivered within 2 weeks.
For ongoing studies, both the dataset and the final report are generally delivered within 4–5 weeks .
For the most accurate delivery timeline, please contact us to confirm the current status of the report.
Yes. The scope of the report can be fully customized to align with your specific research objectives and information requirements.
Please contact us at [email protected], and our team will be happy to discuss your requirements and propose a tailored solution.
Yes. Selected sections of the report can be purchased separately based on your requirements. Please contact us at [email protected] to discuss your needs.
Yes, AI can help gather publicly available information, but its outputs are only as reliable as the data it accesses. Stratview Research reports are built using validated data, extensive primary interviews with industry stakeholders, and the expertise of our experienced research team.
Additionally, many critical insights, including market dynamics, competitive intelligence, and industry-specific trends, are not publicly available and therefore cannot be captured through AI alone.
Tissue diagnostic is the process of documenting a specific tissue obtained. It can also be defined as the diagnosis of a specific tissue, including its measurement and description, as well as the observation of any abnormalities that may be present. This procedure aids in determining the patient's health and disease status. Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and in-situ hybridization are the three major types of tissue diagnostics, with immunohistochemistry (IHC) being the most popular.
Abbott Laboratories, Abcam plc., Agilent Technologies, Inc., Cancer Genetics Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Sakura Finetek Japan Co., Ltd., and Thermo Fisher Scientific Inc are among the key players in the market.
